Apricus Wealth, LLC Pfizer Inc Transaction History

Apricus Wealth, LLC

$150 Million
Q3 2024

A detailed history of Apricus Wealth, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Apricus Wealth, LLC holds 104,970 shares of PFE stock, worth $2.77 Million. This represents 2.03% of its overall portfolio holdings.

Number of Shares

104,970

Previous 100,770 4.17%

Holding current value

$2.77 Million

Previous $2.82 Million 7.73%

% of portfolio

2.03%

Previous 2.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$27.7 - $31.39 $116,340 - $131,838	4,200 Added 4.17%	104,970 $3.04 Million
Q2 2024 Jul 25, 2024	BUY	$25.26 - $29.6 $165,781 - $194,264	6,563 Added 6.97%	100,770 $2.82 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $629,929 - $723,360	24,331 Added 34.82%	94,207 $2.61 Million
Q4 2023 Jan 22, 2024	BUY	$26.13 - $33.94 $305,433 - $396,724	11,689 Added 20.09%	69,876 $2.01 Million
Q3 2023 Oct 24, 2023	BUY	$32.09 - $37.51 $373,046 - $436,053	11,625 Added 24.97%	58,187 $1.93 Million
Q2 2023 Jul 20, 2023	BUY	$36.12 - $41.79 $17,879 - $20,686	495 Added 1.07%	46,562 $1.71 Million
Q1 2023 May 01, 2023	BUY	$39.39 - $51.28 $118,957 - $154,865	3,020 Added 7.02%	46,067 $1.88 Million
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $30,060 - $39,240	-720 Reduced 1.65%	43,047 $2.21 Million
Q3 2022 Oct 31, 2022	SELL	$43.76 - $53.42 $176,571 - $215,549	-4,035 Reduced 8.44%	43,767 $1.92 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $94,223 - $111,719	2,025 Added 4.42%	47,802 $2.51 Million
Q1 2022 Apr 21, 2022	BUY	$45.75 - $56.69 $49,867 - $61,792	1,090 Added 2.44%	45,777 $2.28 Million
Q4 2021 Mar 09, 2022	BUY	$41.32 - $61.25 $1.85 Million - $2.74 Million	44,687 New	44,687 $2.64 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apricus Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apricus Wealth, LLC with notifications on news.

Account

Apricus Wealth, LLC Pfizer Inc Transaction History